KDHSX
Price
$53.70
Change
-$0.11 (-0.20%)
Updated
Jul 3 closing price
Net Assets
814.23M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

KDHSX vs VVIAX

Header iconKDHSX vs VVIAX Comparison
Open Charts KDHSX vs VVIAXBanner chart's image
DWS CROCI Equity Dividend S
Price$53.70
Change-$0.11 (-0.20%)
VolumeN/A
Net Assets814.23M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
KDHSX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
KDHSX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is KDHSX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. KDHSX (814M). KDHSX pays higher dividends than VVIAX: KDHSX (2.61) vs VVIAX (2.18). KDHSX was incepted earlier than VVIAX: KDHSX (20 years) vs VVIAX (25 years). KDHSX (0.78) is less costly to investors than VVIAX (0.05). KDHSX is a more actively managed with annual turnover of: 42.00 vs. VVIAX (9.00). KDHSX has a lower initial minimum investment than VVIAX: KDHSX (2500) vs VVIAX (3000). VVIAX annual gain was more profitable for investors over the last year : 12.03 vs. KDHSX (2.27). VVIAX return over 5 years is better than : 80.13 vs. KDHSX (35.87).
KDHSXVVIAXKDHSX / VVIAX
Total Expense Ratio0.780.051,560%
Annual Report Gross Expense Ratio0.780.051,560%
Fund Existence20 years25 years-
Gain YTD0.3476.1986%
Front LoadN/AN/A-
Min. Initial Investment2500300083%
Min. Initial Investment IRAN/AN/A-
Net Assets814M189B0%
Annual Yield % from dividends2.612.18120%
Returns for 1 year2.2712.0319%
Returns for 3 years11.5935.1733%
Returns for 5 years35.8780.1345%
Returns for 10 years49.49115.6743%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.